34155-39-0

Usage

Uses

Given the limited information available on 1,1-Dimethyl-2-Pyrrolidin-1-yl-ethylamine, it is challenging to list specific applications. However, based on its classification as a pyrrolidine, we can infer potential uses in the following areas:
Used in Organic Synthesis:
1,1-Dimethyl-2-Pyrrolidin-1-yl-ethylamine may be used as a building block or intermediate in the synthesis of more complex organic compounds, particularly those that require the presence of a pyrrolidine ring. Its basic nitrogen atom could facilitate reactions with other molecules, making it a valuable component in the creation of pharmaceuticals, agrochemicals, or other specialty chemicals.
Used in Research and Development:
In the context of scientific research, 1,1-Dimethyl-2-Pyrrolidin-1-yl-ethylamine could be employed as a model compound to study the properties and reactivity of pyrrolidine-containing molecules. This could help researchers understand the behavior of similar compounds and develop new synthetic strategies or applications.

InChI:InChI=1/C8H18N2/c1-8(2,9)7-10-5-3-4-6-10/h3-7,9H2,1-2H3

Upstream product

• 123-75-1 pyrrolidine 
• 79-46-9 2-nitropropane 
• 7440-02-0 nickel 
• 130564-37-3 1-(2-methyl-2-nitropropyl)pyrrolidine 

Relevant academic research and scientific papers

C-3 NOVEL TRITERPENONE WITH C-28 AMIDE DERIVATIVES AS HIV INHIBITORS

The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).

NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to novel betulinic substituted amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, Y, Z1, Z2, Z3 and are Formula (II) as defined herein. The invention novel betulinic substituted amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Storage stable perfusion solution for dihydropteridinones

Disclosed are storage stable aqueous infusible or injectable solutions containing an active substance of general formula (I) wherein the groups L, R1, R2, R3, R4 and R5 have the meanings given in the claims and in the specification, and an amount of a physiologically acceptable acid or mixture of acids sufficient to dissolve the active substance and act as a stabiliser, optionally together with other formulating excipients suitable for parenteral administration, and a process for preparing the infusible or injectable solutions according to the invention.

Method of treating chloroquine-resistant malaria with aminoquinoline derivatives

Novel aminoquinoline derivatives of the general formula STR1 are described. Also described are methods for the treatment of malaria pathogens, particularly chloroquine-resistance malaria pathogens with compounds of formula I or the pharmaceutically acceptable salts and hydrolyzable esters thereof.